The massive Impella Mobile Learning Laboratory made a recent stop at the Bakersfield Heart Hospital, attracting kids and their parents, grandparents, doctors and other community members who came onboard to see the Impella 2.5™ heart pump.
The world’s smallest heart pump, the Impella 2.5 heart pump, provides a safety net for the heart which enables cardiologists to perform complex stenting or angioplasty procedures in the heart on patients with severe heart disease.
Inside the Impella Mobile Learning Laboratory, children and adults alike were introduced to the Impella 2.5, stents, balloon angioplasty and other tools cardiologists use to treat patients with heart disease. All tools were demonstrated and explained. Hands-on participation was encouraged, as visitors discovered the world of the cardiologist and developed a deeper understanding of the heart. It was an exciting time for everyone!
Doctors and healthcare workers learned alongside community members and patients. Below Dr. Singh, a cardiologist from Bakersfield, explained the heart, and the use of the Impella 2.5 in treating heart disease.
The Impella Mobile Learning Laboratory travels around the country visiting hospitals like Bakersfield Heart Hospital, a community hospital in Bakersfield, CA. Community care is an important focus of Bakersfield Heart Hospital, as CEO Michelle Oxford noted “community care means to our patients that they don’t have to travel to larger facilities out of the area when we have physicians in our community that can meet the standard of care for them.”
Dr. Brijesh Bhambi explained “cardiologists at Bakersfield Heart Hospital have performed close to one hundred percutaneous coronary interventions (PCIs) on high-risk patients using the Impella® heart pump, and I actually have a number of patients on the north side of 90 who received the interventions two to five years ago and are still around. That’s amazing.”
Bakersfield Heart Hospital is committed to providing the latest options for medical treatment to its patients, such as the Impella 2.5 heart pump. Be sure to visit the Impella Mobile Learning Laboratory when it comes to your town!
- Learn more about complex heart disease
- See how the Impella 2.5 heart pump works
- Learn about the differences between the Impella 2.5 and the intra-aortic balloon pump
- Read more about the Impella 2.5 and intra-aortic balloon pump
- Read the original articles by O’Neill et al. 2012 and Dangas et al. 2014
- Read more about Bakersfield Heart Hospital
The Impella 2.5 system is a temporary (<6 hours) ventricular support device indicated for use during high-risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high-risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.
Protected PCI and use of the Impella 2.5 is not right for every patient. Patients may not be able to be treated with Impella if they have certain pre-existing conditions, which a cardiologist can determine, such as: severe narrowing of the heart valve, severe peripheral artery disease, clots in blood vessels, or a replacement heart valve or certain heart valve deficiencies. Additionally, use of Impella has been associated with risks, including, but not limited to valvular and vascular injury, bleeding, and limb ischemia in certain patients. Learn more about the Impella devices’ approved indications for use, as well as important safety and risk information at www.protectedpci.com/indications-use-safety-information/.